News | February 12, 2018

Philips Recalls HeartStart MRx Defibrillator, Defect May Cause Device Failure

Philips Recalls HeartStart MRx Defibrillator for Defect that May Cause Device Failure.

February 12, 2018 — Philips is recalling the HeartStart MRx Defibrillator due to a defect in the device's Gas Discharge Tube (GDT) that may prevent the device from working automated external defibrillator (AED) mode, or produce noisy ECGs in manual mode. The U.S. Food and Drug Administration (FDA) last week announced it identified this as a Class I recall, the most serious type of recall. The FDA said use of these devices may cause serious injuries or death.

Philips said the GDT has micro cracks, which allow internal gasses to escape and causes the tubes to not function as expected. This also permits an electrical current surge to cross the device's designated resistors, which will damage the resistors and prevent the device from working while in automated external defibrillator (AED) mode. 

As a result of this GDT defect, the HeartStart MRx may fail at any time, including when delivering repeated shocks in AED mode, or during the periodic Operational Check outlined in the device's Instructions for Use. If the device is used in AED mode after failure, the device will not deliver patient therapy. Continued use of the device in AED mode after failure may lead to serious patient injury or death.

However, the FDA said the HeartStart MRx will continue to work in manual mode after AED mode failure, though the electrocardiogram (ECG) displayed on the device will be noisy, which may make provider interpretation difficult.

On June 13, 2017, Philips issued a Medical Device Correction Notification letter informing customers of the device's risks.The letter directed customers to:
   • Check all inventory for affected models of the HeartStart MRx Defibrillator.
   • Contact Philips if the HeartStart MRx Defibrillator fails to function as intended. If the device fails to function, users:
   • Should switch the device to manual mode (if previously operating in AED mode).
   • May still use the ECG display and waveforms from other monitoring leads to identify a shockable rhythm and deliver shock therapy while in manual mode.
   • May notice the device indicates poor pad placement even though the pads are appropriately positioned.
   • Will be contacted by Philips to repair the affected device(s) once replacement parts are available.

Customers who have questions or need additional information or support regarding this recall should contact their local Philips representative.

The recall is for model numbers M3535A, M3536A. The manufacturing dates are between Sept. 22, 2016 to Oct. 31, 2016, and they were distributed between Sept. 26 to Nov. 2, 2016. The recall includes 71 devices in the United States.

For more information from the FDA.

Read about an earlier HeartStart MRx recall in March 2017 regarding electrical and battery connection issues.

 

Related Content

Zoll Canada Equipping Province of Québec Paramedic Services with X Series Monitor/Defibrillators
News | Defibrillator Monitors | October 16, 2017
October 16, 2017 — Zoll Canada, a subsidiary of Zoll Medical Corp., announced it has won the tender to equip all ambu
Physio-Control Launches HeartSine samaritan PAD 360P Automated External Defibrillator in United States
Technology | Defibrillator Monitors | April 24, 2017
Physio-Control announced April 19 that the company’s HeartSine samaritan PAD 360P (SAM 360P) fully automatic external...
AEDs, automated external defibrillators, requirements, U.S. schools, JACC study
News | Defibrillator Monitors | March 30, 2017
Automated external defibrillators (AEDs) are associated with increased survival of sudden cardiac arrest when installed...
Philips, FDA, class I recall, HeartStart MRx Monitor/Defibrillator
News | Defibrillator Monitors | March 28, 2017
Philips and the U.S. Food and Drug Administration (FDA) announced the company has initiated a recall of its HeartStart...
Zoll, Hospital Wearable Defibrillator, HWD, FDA premarket approval
Technology | Defibrillator Monitors | March 10, 2017
Zoll Medical Corp. announced that the company’s Hospital Wearable Defibrillator (HWD) has been granted premarket...
Zoll LifeVest wearable defibrillator, WEARIT-II Registry results, CardioStim EuroPace 2016
News | Defibrillator Monitors | June 21, 2016
Zoll Medical Corp. announced that patients experience a high one-year survival rate following use of the LifeVest...
defibrillator-monitors, defibrillator monitor

Physio-Control's LifePAK15

Feature | Defibrillator Monitors | February 03, 2014 | Dave Fornell
For U.S. hospitals and emergency medical services (EMS) looking to upgrade their aging defibrillator-monitors, new...
Overlay Init